Ben Felmingham
Mr Ben Felmingham is a paediatric pharmacist who completed his pharmacy training at the Royal Children’s Hospital, Melbourne (RCH). He then went on to specialise in paediatric oncology, in which he is well versed with over 10 years of experience in all paediatric cancer streams including bone marrow transplantation.
In 2021, under the Australian Cardio-oncology Registry (ACOR) umbrella of research work, Ben led the development of the first ever paediatric cardio-oncology guidelines. He has implemented and currently co-ordinates the multidisciplinary cardio-oncology clinic based at RCH.
Ben is currently working as an academic pharmacist and senior research officer within the Murdoch Children’s Research Institute (MCRI). Ben has a growing interest paediatric cardio-oncology as well as the pharmacogenomics field. His passion in these areas have led him to create and promote awareness of the growing importance of cardio-oncology and the importance of incorporating pharmacogenomics into practice. This in turn has led Ben to begin work on multiple research projects where he is expanding his expertise into looking at the effects of pharmacogenomic screening for potential gene-drug interactions, and thus providing and investigating therapeutic recommendations for actionable variants within the paediatric oncology population.
Abstracts this author is presenting: